Reticulocytopenia
Showing 1 - 14 of 14
Pure Red Cell Aplasia Trial in Beijing (Sirolimus)
Completed
- Pure Red Cell Aplasia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 1, 2021
Immunological Pure Red Cell Aplasia Trial (Isatuximab)
Not yet recruiting
- Immunological Pure Red Cell Aplasia
- (no location specified)
Sep 26, 2022
Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder Trial in Calgary (Alemtuzumab, Total Body
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +2 more
-
Calgary, Alberta, CanadaAlberta Children's Hospital
May 25, 2021
Parvovirus B19 Infection in Hereditary Hemolytic Anemias
Active, not recruiting
- Parvovirus B19 Infection
- Supportive treatment with or without red cell transfusion/intravenous immune globulin (IVIG)
-
Sohag, Egypt, Faculty of Medicine, Sohag University
Mar 25, 2021
Uncomplicated P. Falciparum Malaria Trial in Kunar (Artesunate + Sulphadoxine-pyrimethamine)
Completed
- Uncomplicated P. Falciparum Malaria
- Artesunate + Sulphadoxine-pyrimethamine
-
Kunar, AfghanistanNarang, Asadabad, Watapoor district health centres
Oct 9, 2020
Sickle Cell Disease Trial in Worldwide (voxelotor, Placebo)
Chronic Viral Hepatitis B With Delta-agent Trial in Russian Federation (Myrcludex B, PEG IFN alfa-2a, Tenofovir)
Completed
- Chronic Viral Hepatitis B With Delta-agent
- Myrcludex B
- +2 more
-
Chelyabinsk, Russian Federation
- +6 more
Apr 7, 2021
Pure Red Cell Aplasia Trial in Beijing (tacrolimus)
Unknown status
- Pure Red Cell Aplasia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 28, 2018
Fanconi's Anemia, Hematologic Disease Trial run by the NHLBI (Antithymocyte globulin, Cyclosporine)
Completed
- Fanconi's Anemia
- Hematologic Disease
- Antithymocyte globulin
- Cyclosporine
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Mar 3, 2008